ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists Number 64, July 2005 (Replaces Committee Opinion Number 238, July 2000): hemoglobinpathies in pregnancy.
The hemoglobinopathies are a heterogeneous group of single-gene disorders that include the structural hemoglobin variants and the thalassemias. More than 270 million people worldwide are heterozygous carriers of hereditary disorders of hemoglobin, and at least 300,000 affected homozygotes or compound heterozygotes are born each year (1). The purpose of this document is to review the most common hemoglobinopathies and to provide recommendations for the screening and clinical management of hemoglobinopathies during pregnancy.
D000755:Anemia, Sickle Cell / Q000175:diagnosis / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006453:Hemoglobinopathies / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D009774:Obstetrics / Q000592:standards; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis* / Q000628:therapy*; D011256:Pregnancy Outcome; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D013789:Thalassemia / Q000175:diagnosis / Q000628:therapy; D016896:Treatment Outcome